RPL17 and hepatocellular carcinoma: Our findings elucidate the role of arsenic sulfide in combination with anti-PD-1 therapy in HCC eradication and its underlying molecular mechanism, providing a precise scientific rationale and a robust theoretical basis for arsenic sulfide’s application in HCC treatment.